06 Oct 2022
22:01 CEST |
GALAPAGOS |
Galapagos geeft verdere inzichten in de behandeling van colitis ulcerosa tijdens de komende United European Gastroenterology (UEG) Week 2022
|
20103010 Biotechnology |
Other subject |
06 Oct 2022
22:01 CEST |
GALAPAGOS |
Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
|
20103010 Biotechnology |
Other subject |
03 Oct 2022
22:01 CEST |
GALAPAGOS |
Galapagos ontvangt positief CHMP-advies voor update van het Europees label voor Jyseleca® gebaseerd op testiculaire functie veiligheidsgegevens van MANTA/RAy studies
|
20103010 Biotechnology |
Other subject |
03 Oct 2022
22:01 CEST |
GALAPAGOS |
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
|
20103010 Biotechnology |
Other subject |
27 Sep 2022
22:01 CEST |
GALAPAGOS |
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten
|
20103010 Biotechnology |
Other subject |
27 Sep 2022
22:01 CEST |
GALAPAGOS |
Galapagos increases share capital through subscription right exercises
|
20103010 Biotechnology |
Other subject |
29 Aug 2022
22:01 CEST |
GALAPAGOS |
Galapagos receives transparency notification from FMR LLC
|
20103010 Biotechnology |
Other subject |
29 Aug 2022
22:01 CEST |
GALAPAGOS |
Galapagos ontvangt transparantieverklaring van FMR LLC
|
20103010 Biotechnology |
Other subject |
24 Aug 2022
22:01 CEST |
GALAPAGOS |
Galapagos to present at upcoming investor conferences
|
20103010 Biotechnology |
Other subject |
24 Aug 2022
22:01 CEST |
GALAPAGOS |
Galapagos presenteert op komende beleggersconferenties
|
20103010 Biotechnology |
Other subject |
18 Aug 2022
22:01 CEST |
GALAPAGOS |
Galapagos receives transparency notification from FMR LLC
|
20103010 Biotechnology |
Other subject |
18 Aug 2022
22:01 CEST |
GALAPAGOS |
Galapagos ontvangt transparantieverklaring van FMR LLC
|
20103010 Biotechnology |
Other subject |
08 Aug 2022
22:01 CEST |
GALAPAGOS |
Galapagos receives transparency notification from FMR LLC
|
20103010 Biotechnology |
Other subject |
08 Aug 2022
22:01 CEST |
GALAPAGOS |
Galapagos ontvangt transparantieverklaring van FMR LLC
|
20103010 Biotechnology |
Other subject |
04 Aug 2022
22:01 CEST |
GALAPAGOS |
First key steps in pipeline rebuild and strong commercial progress in H1 2022
|
20103010 Biotechnology |
Other subject |
04 Aug 2022
22:01 CEST |
GALAPAGOS |
Eerste belangrijke stappen in heropbouw van pijplijn en sterke commerciële vooruitgang in H1 2022
|
20103010 Biotechnology |
Other subject |
21 Jun 2022
22:03 CEST |
GALAPAGOS |
Galapagos neemt CellPoint en AboundBio over om toegang tot celtherapieën van de volgende generatie te versnellen
|
20103010 Biotechnology |
Other subject |
21 Jun 2022
22:03 CEST |
GALAPAGOS |
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
|
20103010 Biotechnology |
Other subject |
20 Jun 2022
22:01 CEST |
GALAPAGOS |
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten
|
20103010 Biotechnology |
Other subject |
20 Jun 2022
22:01 CEST |
GALAPAGOS |
Galapagos increases share capital through subscription right exercises
|
20103010 Biotechnology |
Other subject |
01 Jun 2022
22:01 CEST |
GALAPAGOS |
Galapagos ontvangt transparantieverklaring van FMR LLC
|
20103010 Biotechnology |
Other subject |
01 Jun 2022
22:01 CEST |
GALAPAGOS |
Galapagos receives transparency notification from FMR LLC
|
20103010 Biotechnology |
Other subject |
25 May 2022
22:01 CEST |
GALAPAGOS |
Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress
|
20103010 Biotechnology |
Other subject |
25 May 2022
22:01 CEST |
GALAPAGOS |
Galapagos laat betrokkenheid bij reumazorg zien op European League Against Rheumatism congres
|
20103010 Biotechnology |
Other subject |
06 May 2022
22:01 CEST |
GALAPAGOS |
Galapagos creates new subscription right plans
|
20103010 Biotechnology |
Other subject |
06 May 2022
22:01 CEST |
GALAPAGOS |
Galapagos creëert nieuwe inschrijvingsrechtenplannen
|
20103010 Biotechnology |
Other subject |
05 May 2022
22:01 CEST |
GALAPAGOS |
Galapagos demonstrates regulatory and commercial progress in Q1 2022
|
20103010 Biotechnology |
Other subject |
05 May 2022
22:01 CEST |
GALAPAGOS |
Galapagos toont regelgevende en commerciële voortgang bij eerste kwartaalresultaten 2022
|
20103010 Biotechnology |
Other subject |
26 Apr 2022
22:01 CEST |
GALAPAGOS |
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board
|
20103010 Biotechnology |
Other subject |
26 Apr 2022
22:01 CEST |
GALAPAGOS |
Galapagos kondigt de benoeming aan van Dr. Paul Stoffels tot Voorzitter van de raad van bestuur
|
20103010 Biotechnology |
Other subject |
28 Mar 2022
08:01 CEST |
GALAPAGOS |
Jyseleca® approved in Japan for ulcerative colitis
|
20103010 Biotechnology |
Other subject |
28 Mar 2022
08:01 CEST |
GALAPAGOS |
Jyseleca® goedgekeurd voor colitis ulcerosa in Japan
|
20103010 Biotechnology |
Other subject |
24 Mar 2022
21:17 CET |
GALAPAGOS |
Correction: Galapagos publiceert 2021 jaarverslag en kondigt buitengewone en jaarlijkse aandeelhoudersvergaderingen aan
|
20103010 Biotechnology |
Other subject |
24 Mar 2022
21:17 CET |
GALAPAGOS |
Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
|
20103010 Biotechnology |
Other subject |
24 Mar 2022
21:01 CET |
GALAPAGOS |
Galapagos publiceert 2021 jaarverslag en kondigt buitengewone en jaarlijkse aandeelhoudersvergaderingen aan
|
20103010 Biotechnology |
Other subject |
24 Mar 2022
21:01 CET |
GALAPAGOS |
Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
|
20103010 Biotechnology |
Other subject |
18 Mar 2022
22:01 CET |
GALAPAGOS |
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten
|
20103010 Biotechnology |
Other subject |
18 Mar 2022
22:01 CET |
GALAPAGOS |
Galapagos increases share capital through subscription right exercises
|
20103010 Biotechnology |
Other subject |
24 Feb 2022
22:01 CET |
GALAPAGOS |
Galapagos 2021 results set stage for future growth
|
20103010 Biotechnology |
Other subject |
24 Feb 2022
22:01 CET |
GALAPAGOS |
Resultaten Galapagos 2021 zetten de toon voor toekomstige groei
|
20103010 Biotechnology |
Other subject |
03 Feb 2022
22:01 CET |
GALAPAGOS |
Galapagos receives transparency notification from EcoR1 Capital
|
20103010 Biotechnology |
Other subject |
03 Feb 2022
22:01 CET |
GALAPAGOS |
Galapagos ontvangt transparantieverklaring van EcoR1 Capital
|
20103010 Biotechnology |
Other subject |
02 Feb 2022
22:01 CET |
GALAPAGOS |
Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s and Colitis Organization (ECCO) annual congress
|
20103010 Biotechnology |
Other subject |
02 Feb 2022
22:01 CET |
GALAPAGOS |
Galapagos geeft meer inzicht in de behandeling van colitis ulcerosa op het jaarlijkse congres van de European Crohn's and Colitis Organization (ECCO)
|
20103010 Biotechnology |
Other subject |
26 Jan 2022
22:40 CET |
GALAPAGOS |
Galapagos creates new subscription right plan
|
20103010 Biotechnology |
Other subject |
26 Jan 2022
22:40 CET |
GALAPAGOS |
Galapagos creëert nieuw inschrijvingsrechtenplan
|
20103010 Biotechnology |
Other subject |
26 Jan 2022
22:01 CET |
GALAPAGOS |
Galapagos appoints Paul Stoffels as Chief Executive Officer
|
20103010 Biotechnology |
Other subject |
26 Jan 2022
22:01 CET |
GALAPAGOS |
Galapagos benoemt Paul Stoffels tot Chief Executive Officer
|
20103010 Biotechnology |
Other subject |
18 Jan 2022
22:01 CET |
GALAPAGOS |
JYSELECA®▼ (FILGOTINIB) KRIJGT VERGUNNING VOOR DE BEHANDELING VAN VOLWASSEN PATIËNTEN MET MATIGE TOT ERNSTIGE ACTIEVE COLITIS ULCEROSA IN GROOT-BRITTANNIË
|
20103010 Biotechnology |
Other subject |
18 Jan 2022
22:01 CET |
GALAPAGOS |
JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREAT BRITAIN
|
20103010 Biotechnology |
Other subject |